Clinical Trial 41482

Evanston, IL 60201

Study Summary:

Do you have acute migraines?
If so, you may qualify for a randomized, double-blind, single-dose, placebo-controlled study to assess the efficacy and safety of an investigational medication  for the acute treatment of migraine in adults with inadequate response to prior acute treatments.


Qualified Participants Must:

• Be male or female ages 18 to 65
• Have a history of episodic migraine for at least 1 year
• Have 2 to 8 migraine attacks per month
• Have had inadequate response to prior acute treatments

Qualified Participants May Receive:

Compensation for time and travel. 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.